OOIR: Observatory of International Research

Papers

(The TQCC of Allergy and Asthma Proceedings is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
For the Patient	77
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	71
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery	41
Impact of steroids on the immune profiles of children with asthma living in the inner-city	32
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	32
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	30
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	29
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	25
COVID-19 in Italian children and adolescents: The role of allergy and asthma	23
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	22
Venom allergen immunotherapy	20
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	20
Operationalizing shared decision making in clinical practice	19
Future directions in allergen immunotherapy	19
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	19
For the patient	19
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	18
For the Patient	18
TEV/FEV₃ as a coherent metric of small airway dysfunction in childhood asthma	18
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii	18
The influence of sea breeze on mold spore dispersion	17
For the Patient	17
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	16
Evaluation and management of chronic cough in adults	16
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	16

For the Patient	16
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	16
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	15
Treatment strategies for postviral olfactory dysfunction: A systematic review	15
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	14
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	14
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	13
A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure	13
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	13
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	13
Diagnostic utility of basophil CD203c expression in β-lactam allergy	12
For the Patient	12
Studies of mitochondrial and nuclear DNA released from food allergen‐activated neutrophils. Implications for non‐IgE food allergy	11
Evaluation of the peripheral blood eosinophil count as a predictor for fractional exhaled nitric oxide or bronchodilator reversibility test outcome	11
For the Patient	11
Navigating the management complexity in long-term asymptomatic immunodeficiency	11
For the patient	10
Guidelines for management of hereditary angioedema: What is new? What is missing?	10
Effects of mechanical washing and drying on the removal of pet allergens	10
Evaluation of anaphylaxis recurrence and adrenaline autoinjector use in childhood	10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	10
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	10
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	10
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis	9
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	9
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	9
Effect of COVID-19 on hereditary angioedema activity and quality of life	9
Evaluation of atopic diseases in patients with allergic contact dermatitis	9
The long COVID syndrome: A conundrum for the allergist/immunologist	8
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist	8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	8
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	8
Paucigranulocytic asthma: Do sputum macrophages matter?	8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	8
Clinical features of anaphylaxis in children	8
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	8
Hematopoietic stem cell transplantation for primary immunodeficiency	8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	8
Benralizumab in the management of rare primary eosinophilic lung diseases	8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	8
Treatment options for chronic rhinosinusitis with nasal polyps	7
Safety of ciclesonide in children with asthma: A review of randomized controlled trials	7
Overview of secondary immunodeficiency	7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	7
Food-induced anaphylaxis in early childhood and factors associated with its severity	7
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	7

Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	7
Assessing cross-reactivity in allergen immunotherapy	7
The association of timothy grass allergy and cat ownership on cat sensitization	7
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	7
Caregiver perceptions and attitudes associated with oral immunotherapy on social media	7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	7
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida	6
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	6
A masquerade of recurrent anaphylaxis	6
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?	6
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	6
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	6
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	6
Curcumin does not significantly affect immediate skin tests	6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	6
For the Patient	6